Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Great news!

is not worth 67 cents.

Last I looked market equilibrium is a function of supply and demand.

As it stands right now there is a potential demand given the right MARKETTING

Today there are a group of us willing to place a relatively small bet on

a BB stock. yes we have some in our SEP/IRA?401K etc but one Fidelity couldquadruplethe supply.

It'snot that institutions do not wish to buy it's that they are not allowed to buy.

Also once the stock becomes marginable ( above 5) then those of you who this week were begging for monmey would be able to leverage their own invetsment.

R/S splits only hurt companies that don;t have a financial leg to stand on. If you have real value and are on a real market you will quickly attract real investors.

Share
New Message
Please login to post a reply